Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'20
Mar'19
Mar'18
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 560.00% vs -85.71% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 0.00% vs -42.86% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 215.01% vs 25,550.00% in Mar 2025
Compare Balance Sheet Results of Venmax Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
11.58
50.10
-38.52
-76.89%
Share Warrants & Outstandings
Total Reserve
0.69
-0.48
1.17
243.75%
Shareholder's Funds
14.12
49.62
-35.50
-71.54%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.05
0.00
0.05
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.05
0.00
0.05
0.00%
Deferred Tax Assets / Liabilities
0.00
-0.30
0.30
100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.17
-0.17
-100.00%
Total Non-Current Liabilities
0.05
-0.12
0.17
141.67%
Current Liabilities
Trade Payables
1.68
2.12
-0.44
-20.75%
Other Current Liabilities
0.04
2.62
-2.58
-98.47%
Short Term Borrowings
0.28
9.75
-9.47
-97.13%
Short Term Provisions
0.04
2.28
-2.24
-98.25%
Total Current Liabilities
2.03
16.77
-14.74
-87.90%
Total Liabilities
16.20
66.27
-50.07
-75.55%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.04
121.07
-121.03
-99.97%
Less: Accumulated Depreciation
0.00
66.02
-66.02
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
55.05
-55.01
-99.93%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
0.78
-0.78
-100.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
0.04
55.83
-55.79
-99.93%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
1.00
1.82
-0.82
-45.05%
Sundry Debtors
1.43
0.04
1.39
3,475.00%
Cash and Bank
1.22
0.70
0.52
74.29%
Other Current Assets
0.02
2.98
-2.96
-99.33%
Short Term Loans and Advances
12.49
4.90
7.59
154.90%
Total Current Assets
16.16
10.44
5.72
54.79%
Net Current Assets (Including Current Investments)
14.13
-6.34
20.47
322.87%
Total Current Assets Excluding Current Investments
16.16
10.44
5.72
54.79%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
16.20
66.27
-50.07
-75.55%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.33
9.75
-9.42
-96.62%
Book Value per share (adjusted)
10.60
9.90
0.70
7.07%
Annual - Borrowings
Borrowings 0.33 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 560.00% vs -85.71% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.00% vs -42.86% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 16.16 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 215.01% vs 25,550.00% in Mar 2025